Tag Archives: drug cost

New Report Emphasizes the Role of Patent Protection in the Global Diffusion of New Drugs

medical_research

A new report from the National Bureau of Economic Research (NBER) has determined that strong patent protection accelerates the speed at which new drugs are launched in different countries. Providing affordable access is often challenged by the need to provide adequate incentives for developing new drugs, and ensuring affordable prices once they develop. Often neglected in the larger debate is that the speed at which drugs are launched and adopted in new countries is one Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Breast Cancer

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide ‘substantially much higher health benefits than the traditional drugs.’ “Our study suggests that although specialty drugs often have higher costs than traditional drugs, they also tend to confer greater benefits and hence may still offer reasonable value for money,” wrote the researchers at the Boston-based Center for Value and Risk in Health. The study authors judged the drugs’ performance by Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , ,

WSJ Editorial: The Medical Innovation Threat

???????????????????????????????

An editorial in today’s Wall Street Journal looks at the rising threat the American insurance industry’s increasingly loud attacks on Sovaldi, a revolutionary new Hepatitis C treatment pose for medical innovation and the development of new specialty drugs. As the editors rightly note, “Sovaldi is the kind of medicine that the drug scolds claim to want—a true scientific advance with a near-perfect cure rate for Hepatitis C, the liver-destroying virus that infects one of every 100 Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

New York Times Building

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the attention the cost has received to date, those attacking the drug are “looking at the costs of Sovaldi in the wrong way.” Sanger-Katz acknowledges that these one-time treatments can be a ‘shock to the system,’ but notes the value far outweighs the expense since it cures the disease in the majority of patients, preventing further costly treatments and care. Sanger-Katz Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Cancer Death-Panel App

Annie Cavanagh. Wellcome Images

In an article for the New York Post, Robert Goldberg, vice president of the Center for Medicine in the Public Interest, wrote about an app that will use an algorithm like those health plans apply to limit access to innovative treatments: “At ASCO’s national conference, Dr. Lee Newcomer, United Healthcare’s medical director, said the ‘motives [of insurers] are viewed with suspicion when it comes to deciding whether a treatment is cost-effective. So having ASCO play Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,